While there is no cure for Age-Related Macular Degeneration (AMD), the leading cause of blindness in seniors, there are potential new treatments that offer hope that this sight threatening disease may be slowed, or perhaps stopped or reversed. For more than a decade, Ophthalmologists’ only options have been to treat Wet AMD with monthly injections of an Anti-VEGF drug that blocks damaging proteins, and for Dry AMD, with a special formulation of antioxidant vitamins. But revolutionary new research suggests a future with more ways to protect people from blindness due to AMD. Developments in Wet AMD treatment include a tiny refillable reservoir smaller than a grain of rice that is surgically implanted into the wall of the eye under the eyelid that continuously releases the Anti-VEGF drug, and a gene therapy that helps to produce its own Anti-VEGF medicine. New Dry AMD treatments include drugs that target a part of the immune system identified as a culprit in Dry AMD, as well as the replacement of dying Retinal cells through stem cell transplants. Learn about these, and other revolutionary new treatments for AMD at http://bit.ly/3pKi68V
